The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains

Published:2021-09 Issue:9 Volume:29 Page:2707-2722
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Dai Zhenyu,Mu Wei,Zhao Ya,Jia Xiangyin,Liu Jianwei,Wei Qiaoe,Tan Taochao,Zhou Jianfeng

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N. Engl. J. Med.,2017

2. CD19 chimeric antigen receptor therapy for refractory aggressive B-cell lymphoma;Jacobson;J. Clin. Oncol.,2019

3. The response to lymphodepletion impacts PFS in aggressive non-Hodgkin lymphoma patients treated with CD19 CAR T cells;Hirayama;Blood,2019

4. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci. Transl. Med.,2014

5. CD19 CAR-T cells combined with ibrutinib to induce complete remission in CLL;Gill;J. Clin. Oncol.,2017

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fratricide-resistant CD7-CAR T cells in T-ALL;Nature Medicine;2024-09-03

2. Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning;Molecular Therapy: Oncology;2024-09

3. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

4. Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope;Frontiers in Immunology;2024-08-13

5. CD5 deletion enhances the antitumor activity of adoptive T cell therapies;Science Immunology;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3